AI-augmented Discovery Platform to progress Microbiome Multiomics

The Earlham Institute has announced a partnership with Eagle Genomics focused on providing critical tools to both academia and industry for exploration of complex microbiome data, while accelerating data-driven collaboration.

With a wealth of expertise in genomics and bioinformatics the Institute has already developed a number of successful tools and datasets for bioinformaticians - while Eagle Genomics’ applies network science to multi-dimensional life sciences data - including environmental and clinical metagenomes for multi-omics analysis.

Anthony Finbow, CEO of Eagle Genomics, stated: "Eagle Genomics’ industry-leading open platform is helping drive the digital reinvention of life sciences R&D across numerous industries, from AgBio and food through to healthcare, personal care and beauty. 

“Our partnership with the Earlham Institute is a clear demonstration of our commitment to enable a radical, global shift in microbiome science-led innovation. By harnessing nature - including its complex networks and associated multi-dimensional data - we can help tackle the world’s Grand Challenges while unlocking significant economic potential." 

Dr Liliya Serazetdinova, Head of Business Development and Impact at the Earlham Institute, said: “This partnership is part of a big data revolution in terms of how multi-omics data will be accessed and analysed - combining open science and commercial R&D to benefit each partner and society.

“Eagle Genomics’ platform gives our scientists the opportunity to share their work more widely, establish new connections, and use it as a testing ground - interrogating and integrating new datasets, as well as developing new tools and pipelines - to further advance our research and apply to the biotech industry.

“We’re really excited to be working with Eagle Genomics and look forward to seeing how this platform evolves, and involves more partners in the coming months.”

Eagle Genomics is currently in discussions with a range of other organisations to ensure that its platform continues to evolve as the burgeoning global life sciences knowledge discovery hub.

More information online